Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 EUR)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 356 Less Arrow 197 More Arrow 1,805
Earnings before taxes -11,965 Less Arrow -12,665 More Arrow -9,937
EBITDA -13,116 Less Arrow -13,388
Total assets 19,641 More Arrow 32,609 Less Arrow 25,442
Current assets 14,456 More Arrow 26,852 Less Arrow 19,559
Current liabilities 3,371 Less Arrow 2,455 Less Arrow 1,829
Equity capital 16,252 More Arrow 30,100 Less Arrow 23,517
- share capital 3,134 More Arrow 3,381 Less Arrow 2,340
Employees (average) 22 Less Arrow 20 Less Arrow 11

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 82.7% More Arrow 92.3% More Arrow 92.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -59.1% More Arrow -38.2% More Arrow -32.0%
Current ratio 428.8% More Arrow 1093.8% Less Arrow 1069.4%
Return on equity (ROE) -73.6% More Arrow -42.1% Less Arrow -42.3%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 More Arrow 9 Less Arrow 4
Chg. No. of employees % 10% More Arrow 82% Less Arrow 57%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.